Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2018, Article ID 8025951, 6 pages
https://doi.org/10.1155/2018/8025951
Research Article

Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor, and Pigment Epithelium-Derived Factor Expression in the Neovascular Iris in Retinal Diseases

1Department of Ophthalmology, People’s Hospital, Peking University, Beijing, China
2Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan
3Department of Ophthalmology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
4Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

Correspondence should be addressed to De-Kuang Hwang; moc.liamg@kbg59m and Yong Tao; moc.361@gnoyoatrd

Received 1 September 2017; Revised 7 February 2018; Accepted 13 March 2018; Published 11 April 2018

Academic Editor: Lisa Toto

Copyright © 2018 Heng Miao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Gartner and P. Henkind, “Neovascularization of the iris (rubeosis iridis),” Survey of Ophthalmology, vol. 22, no. 5, pp. 291–312, 1978. View at Publisher · View at Google Scholar · View at Scopus
  2. L. C. Olmos and R. K. Lee, “Medical and surgical treatment of neovascular glaucoma,” International Ophthalmology Clinics, vol. 51, no. 3, pp. 27–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. G. B. Rodrigues, R. Y. Abe, C. Zangalli et al., “Neovascular glaucoma: a review,” International Journal of Retina and Vitreous, vol. 2, no. 1, p. 26, 2016. View at Publisher · View at Google Scholar
  4. S. Watanabe, N. Morisaki, M. Tezuka et al., “Cultured retinal pericytes stimulate in vitro angiogenesis of endothelial cells through secretion of a fibroblast growth factor-like molecule,” Atherosclerosis, vol. 130, no. 1-2, pp. 101–107, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. G. C. Brown, L. E. Magargal, A. Schachat, and H. Shah, “Neovascular glaucoma. Etiologic considerations,” Ophthalmology, vol. 91, no. 4, pp. 315–320, 1984. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Spaulding, “Rubeosis iridis in retinoblastoma and pseudoglioma,” Transactions of the American Ophthalmological Society, vol. 76, pp. 584–609, 1978. View at Google Scholar
  7. X. R. Hou, H. Miao, Y. Tao, X. X. Li, and I. Y. Wong, “Expression of cytokines on the iris of patients with neovascular glaucoma,” Acta Ophthalmologica, vol. 93, no. 2, pp. e100–e104, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Schagat, L. Kiak, and M. Mandrekar, “RNA purification kit: comparison, yield, quality, and real-time, RT-PCR performance,” Promega Notes, vol. 99, pp. 12–15, 2008. View at Google Scholar
  9. Y. Wei, D. Weng, F. Li et al., “Involvement of JNK regulation in oxidative stress-mediated murine liver injury by microcystin-LR,” Apoptosis, vol. 13, no. 8, pp. 1031–1042, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Ozaki, T. Yamashita, and S. Ishiguro, “Ca2+-induced release of mitochondrial m-calpain from outer membrane with binding of calpain small subunit and Grp75,” Archives of Biochemistry and Biophysics, vol. 507, no. 2, pp. 254–261, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. F. M. Damico, “Angiogenesis and retinal diseases,” Arquivos Brasileiros de Oftalmologia, vol. 70, no. 3, pp. 547–553, 2007. View at Publisher · View at Google Scholar
  12. T. H. Lim, S. H. Bae, Y. J. Cho, J. H. Lee, H. K. Kim, and Y. H. Sohn, “Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma,” Korean Journal of Ophthalmology, vol. 23, no. 3, pp. 188–192, 2009. View at Publisher · View at Google Scholar
  13. Y. G. Kim, S. Hong, C. S. Lee et al., “Level of vascular endothelial growth factor in aqueous humor and surgical results of Ahmed glaucoma valve implantation in patients with neovascular glaucoma,” Journal of Glaucoma, vol. 18, no. 6, pp. 443–447, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Sasamoto, Y. Oshima, A. Miki et al., “Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study,” Journal of Ocular Pharmacology and Therapeutics, vol. 28, no. 1, pp. 41–48, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Tolentino, “Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease,” Survey of Ophthalmology, vol. 56, no. 2, pp. 95–113, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Gupta, R. Jha, A. Rao, G. Kong, and R. Sihota, “The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma,” European Journal of Ophthalmology, vol. 19, no. 3, pp. 435–441, 2009. View at Publisher · View at Google Scholar
  17. T. Kubota, A. Tawara, Y. Hata, A. Khalil, and H. Inomata, “Neovascular tissue in the intertrabecular spaces in eyes with neovascular glaucoma,” British Journal of Ophthalmology, vol. 80, no. 8, pp. 750–754, 1996. View at Publisher · View at Google Scholar
  18. J. Nadal, E. Carreras, B. Kudsieh, and M. I. Canut, “Neovascular glaucoma treatment with extraction of anterior chamber fibrovascular tissue,” JAMA Ophthalmology, vol. 131, no. 8, pp. 1083–1085, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Bikfalvi, S. Klein, G. Pintucci, and D. B. Rifkin, “Biological roles of fibroblast growth factor-2,” Endocrine Reviews, vol. 18, no. 1, pp. 26–45, 1997. View at Publisher · View at Google Scholar
  20. J. Tombran-Tink and L. V. Johnson, “Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells,” Investigative Ophthalmology & Visual Science, vol. 30, no. 8, pp. 1700–1707, 1989. View at Google Scholar
  21. D. W. Dawson, O. V. Volpert, P. Gillis et al., “Pigment epithelium-derived factor: a potent inhibitor of angiogenesis,” Science, vol. 285, no. 5425, pp. 245–248, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Matsuyama, N. Ogata, M. Matsuoka et al., “Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy,” Molecular Vision, vol. 14, pp. 992–996, 2008. View at Google Scholar
  23. N. Mohan, F. Monickaraj, M. Balasubramanyam, M. Rema, and V. Mohan, “Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy,” Journal of Diabetes and its Complications, vol. 26, no. 5, pp. 435–441, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Murugeswari, D. Shukla, A. Rajendran, R. Kim, P. Namperumalsamy, and V. Muthukkaruppan, “Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales’ disease,” Retina, vol. 28, no. 6, pp. 817–824, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Elayappan, H. Ravinarayannan, S. P. B. S. Pasha, K. Lee, and S. Gurunathan, “PEDF inhibits VEGF- and EPO- induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation,” Angiogenesis, vol. 12, no. 4, pp. 313–324, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Matsuyama, N. Ogata, N. Jo, C. Shima, M. Matsuoka, and M. Matsumura, “Levels of vascular endothelial growth factor and pigment epithelium-derived factor in eyes before and after intravitreal injection of bevacizumab,” Japanese Journal of Ophthalmology, vol. 53, no. 3, pp. 243–248, 2009. View at Publisher · View at Google Scholar · View at Scopus